EOLS
EOLS
NASDAQ · Pharmaceuticals

Evolus Inc

$5.84
-0.17 (-2.83%)
As of Aug 8, 2:01 AM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +778.3% upside
Low Target $37.24
Average Target $51.29
High Target $70.77
Current Price $5.84
Current
$5.84
Target
$51.29
$37.24 $51.29 avg $70.77
Scenario Analysis
Bear Case
$37.24
537.7%
Low target
Base Case
$51.29
+778.3%
Avg target
Bull Case
$70.77
+1,111.8%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$7.95
-26.5% from high
52-Week Low
$3.86
+51.3% from low
Target vs 52W High
$51.29
+545.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%